Neola Medical EN
  • Lung Monitoring
  • The technology
  • Our Studies
  • About Us
  • Career
  • Investors
    • To invest in Neola Medical
    • Risks and uncertainties
    • Stock information
    • Annual General Meeting (Swedish)
    • Corporate governance
    • Certified Adviser
    • Rights Issues (Swedish)
      • Riktad Emission 2023
      • Företrädesemission 2022
      • IPO 2020
        • Teckningsoptioner av serie TO1
    • Investor Relations
    • Investor letters
    • Presentations
    • Press Releases
    • Reports and Financial Calendar
  • News
    • Press Releases
    • Articles and posts
Select Page

Neola Medical AB (publ) Delårsrapport januari-september 2020

Nov 11, 2020

Tredje kvartalet – Listning på Nasdaq First North Growth Market med kraftigt övertecknad nyemission

Läs rapporten här:

Neola Medical AB (publ) Delårsrapport jan-sept 2020

About Neola Medical

Neola Medical AB (publ) is revolutionizing neonatal intensive care with Neola®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. Neola® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

Sweden, HQ

Neola Medical AB
Ideon Gateway
Scheelevägen 27
223 63 Lund
info@neolamedical.com

U.S. Office

Neola Medical, Inc.
Nordic Innovation House
470 Ramona Street PMB
Palo Alto CA 94301-1707
info@neolamedical.com

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy